9,10-dimethyl-1,2-benzanthracene has been researched along with thalidomide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Napalkov, NP | 1 |
| Best, JB; Morita, M | 1 |
| Ge, JP; Yang, Y; Zhou, ZT | 1 |
| Altieri, S; Aromando, RF; Bortolussi, S; Garabalino, MA; Heber, EM; Itoiz, ME; Molinari, AJ; Monti Hughes, A; Portu, AM; Pozzi, EC; Saint Martin, G; Schwint, AE; Thorp, SI; Trivillin, VA | 1 |
| Frenkel, DD; Gorev, NP; Ionov, ID; Roslavtseva, LA | 1 |
2 review(s) available for 9,10-dimethyl-1,2-benzanthracene and thalidomide
| Article | Year |
|---|---|
[Transplacental carcinogenesis].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Abnormalities, Drug-Induced; Adenocarcinoma; Animals; Carcinogens; Cricetinae; Diethylstilbestrol; Embryo, Mammalian; Female; Gestational Age; Humans; Inactivation, Metabolic; Maternal-Fetal Exchange; Mice; Neoplasms; Neoplasms, Experimental; Nitroso Compounds; Organ Culture Techniques; Pregnancy; Rats; Teratogens; Thalidomide; Uterine Cervical Neoplasms; Vaginal Neoplasms | 1977 |
Planarians as a model system for in vitro teratogenesis studies.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Behavior, Animal; Benz(a)Anthracenes; Benzo(a)pyrene; Benzopyrenes; Cadmium; Caffeine; Chlordan; Colchicine; Dactinomycin; Demecolcine; Drug Evaluation, Preclinical; Ethanol; Lead; Mercury; Models, Biological; Planarians; Puromycin; Reproduction; Teratogens; Thalidomide; Turbellaria | 1982 |
3 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and thalidomide
| Article | Year |
|---|---|
Effects of thalidomide on DMBA-induced oral carcinogenesis in hamster with respect to angiogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Carcinogens; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Chemoprevention; Cricetinae; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Precancerous Conditions; RNA, Messenger; Thalidomide; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2009 |
Assessing advantages of sequential boron neutron capture therapy (BNCT) in an oral cancer model with normalized blood vessels.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cricetinae; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Phenylalanine; Precancerous Conditions; Thalidomide | 2015 |
Cetirizine and thalidomide synergistically inhibit mammary tumorigenesis and angiogenesis in 7,12-dimethylbenz(a)anthracene-treated rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Apoptosis; Blotting, Western; Cell Proliferation; Cetirizine; Drug Synergism; Female; Fibroblast Growth Factor 2; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Thalidomide; Vascular Endothelial Growth Factor A | 2018 |